Mangoceuticals (MGRX) Assets Average (2023 - 2026)

Mangoceuticals' Assets Average history runs 4 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• In Q1 2026, Assets Average fell 17.74% year-over-year to $15.3 million; the TTM figure through Mar 2026 stood at $15.3 million (down 17.74% YoY), while the FY2025 annual figure was $15.7 million, up 91.58% from the prior year.
• Assets Average came in at $15.3 million for Q1 2026 at Mangoceuticals, down from $16.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $21.3 million in Q2 2025 to a low of $676120.0 in Q1 2024.
• A 4-year average of $10.7 million and a median of $15.0 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average sank 73.58% in 2024 and jumped 2645.4% in 2025, its largest moves.
• Mangoceuticals' Assets Average stood at $1.3 million in 2023, then jumped by 1039.8% to $15.1 million in 2024, then climbed by 8.15% to $16.3 million in 2025, then dropped by 6.38% to $15.3 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $15.3 million, $16.3 million, and $18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison